PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.40%
Revenue growth similar to AVGO's 4.40%. Walter Schloss would see if both companies share industry tailwinds.
5.54%
Gross profit growth 1.25-1.5x AVGO's 4.90%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
-2.20%
Negative EBIT growth while AVGO is at 18.43%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-2.95%
Negative operating income growth while AVGO is at 18.43%. Joel Greenblatt would press for urgent turnaround measures.
1.99%
Net income growth under 50% of AVGO's 60.08%. Michael Burry would suspect the firm is falling well behind a key competitor.
1.65%
EPS growth under 50% of AVGO's 58.62%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
1.67%
Diluted EPS growth under 50% of AVGO's 57.14%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.22%
Share reduction more than 1.5x AVGO's 2.88%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.22%
Diluted share reduction more than 1.5x AVGO's 2.78%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.05%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
54.47%
Positive OCF growth while AVGO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
319.48%
Positive FCF growth while AVGO is negative. John Neff would see a strong competitive edge in net cash generation.
36.34%
10Y revenue/share CAGR under 50% of AVGO's 861.53%. Michael Burry would suspect a lasting competitive disadvantage.
7.05%
5Y revenue/share CAGR under 50% of AVGO's 93.24%. Michael Burry would suspect a significant competitive gap or product weakness.
-15.54%
Negative 3Y CAGR while AVGO stands at 66.58%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
138.05%
10Y OCF/share CAGR under 50% of AVGO's 884.95%. Michael Burry would worry about a persistent underperformance in cash creation.
-10.13%
Negative 5Y OCF/share CAGR while AVGO is at 46.62%. Joel Greenblatt would question the firm’s operational model or cost structure.
-25.04%
Negative 3Y OCF/share CAGR while AVGO stands at 13.16%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
93.78%
Below 50% of AVGO's 624.61%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-11.27%
Negative 5Y net income/share CAGR while AVGO is 162.06%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-40.93%
Negative 3Y CAGR while AVGO is 25.27%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
93.15%
Below 50% of AVGO's 1097.33%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
108.41%
5Y equity/share CAGR at 50-75% of AVGO's 169.39%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
56.21%
Below 50% of AVGO's 157.41%. Michael Burry suspects a serious short-term disadvantage in building book value.
330.83%
Below 50% of AVGO's 1839.26%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
68.63%
5Y dividend/share CAGR at 50-75% of AVGO's 97.33%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
27.31%
3Y dividend/share CAGR at 50-75% of AVGO's 38.80%. Martin Whitman might see a weaker short-term approach to distributing cash.
2.39%
AR growth is negative/stable vs. AVGO's 10.69%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
0.56%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.47%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.14%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
-2.10%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
4.18%
R&D growth drastically higher vs. AVGO's 4.64%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
2.20%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.